Buprenorphine Induction Low-Dose to Depot (BUILD2depot): development of safe rapid transfer to depot medication and Go/NoGo testing potential of remote community-based monitoring.
We use cookies to keep your session secure, remember your preferences, and analyse site traffic with Google Analytics.
By continuing to use GrantFunds you agree to our
Privacy Policy
and
Terms of Use.